Liu et al. [9] reported that the HDAC inhibitor MS-275, in combination with cAMP activators, could induce U87 cells and GSCs to differentiate into neuron-like cells, and these neuronal transformations significantly inhibited the proliferation of glioma cells. This evidence concerns the gene HDAC9 and central nervous system cancer.